NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 82 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,458 | -59.3% | 21,923 | -1.4% | 0.00% | – |
Q2 2023 | $57,583 | -50.6% | 22,233 | -22.2% | 0.00% | – |
Q1 2023 | $116,590 | -17.9% | 28,576 | +1.1% | 0.00% | – |
Q4 2022 | $141,930 | -88.7% | 28,273 | -70.5% | 0.00% | -100.0% |
Q3 2022 | $1,252,000 | +37.6% | 95,686 | +34.8% | 0.00% | 0.0% |
Q2 2022 | $910,000 | -5.1% | 70,996 | +12.9% | 0.00% | 0.0% |
Q1 2022 | $959,000 | -59.1% | 62,888 | -22.1% | 0.00% | -50.0% |
Q1 2021 | $2,346,000 | +25.1% | 80,692 | +30.4% | 0.00% | 0.0% |
Q4 2020 | $1,875,000 | +83.3% | 61,875 | -3.7% | 0.00% | +100.0% |
Q3 2020 | $1,023,000 | -10.5% | 64,282 | +11.0% | 0.00% | -50.0% |
Q2 2020 | $1,143,000 | – | 57,894 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |